Literature DB >> 12845839

[CO2-laser decortication: an efficient alternative to radiotherapy in the treatment of T1a carcinomas of the glottis].

K M Goor1, H F Mahieu, C R Leemans, A J Peeters, J A Langendijk, M van Agthoven.   

Abstract

OBJECTIVE: Given that CO2-laser decortication and radiotherapy are equally effective in the treatment of T1a glottic carcinomas, to determine which of the two is most efficient with respect to treatment costs.
DESIGN: Retrospective analysis.
METHOD: The costs of both treatment modalities from the first visit to the Free University Medical Centre, Amsterdam, the Netherlands, until two years after the start of the treatment were calculated, based on the medical consumption of 89 patients who were treated with curative intent for a T1a glottic carcinoma in the years 1995-1999.
RESULTS: The total costs from diagnosis until two years after the start of treatment were [symbol: see text] 7,253,- for radiotherapy and [symbol: see text] 3,864,- for CO2-laser decortication. These amounts included the costs of diagnosis and treatment of any recurrence or benign laryngeal disorders occurring within the two-year interval. The difference was statistically significant.
CONCLUSION: Radiotherapy was significantly more expensive than CO2-laser decortication. Therefore CO2-laser decortication is an efficient alternative to radiotherapy in the treatment of eligible patients with T1a glottic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845839

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  4 in total

1.  Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas.

Authors:  Michel van Agthoven; Hélène A G Heule-Dieleman; Paul P Knegt; Johannes H A M Kaanders; Robert J Baatenburg de Jong; Bernd Kremer; C René Leemans; Henri A M Marres; Johannes J Manni; Johannes A Langendijk; Peter C Levendag; Reina E Tjho-Heslinga; Joseph M A de Jong; Maarten F de Boer; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-14       Impact factor: 2.503

Review 2.  Health status and voice outcome after treatment for T1a glottic carcinoma.

Authors:  A Jeanne G E Peeters; Christine D L van Gogh; Kim M Goor; Irma M Verdonck-de Leeuw; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-09       Impact factor: 2.503

3.  Prospective evaluation of voice outcome during the first two years in male patients treated by radiotherapy or laser surgery for T1a glottic carcinoma.

Authors:  Christine D L van Gogh; Irma M Verdonck-de Leeuw; Jeanne Wedler-Peeters; Johannes A Langendijk; Hans F Mahieu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

4.  The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.

Authors:  Addy C G van Hooren; Jolijn Brouwer; Remco de Bree; Otto S Hoekstra; C René Leemans; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-29       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.